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I N T R O D U C T I O N
Many widely prescribed anticonvulsants and local anes-
thetics are use-dependent inhibitors of neuronal Na
+ 
channels.  These  drugs  bind  preferentially,  although 
with slow kinetics, to the inactivated rather than to the 
resting state of the voltage-gated Na
+ channel (Lipicky 
et al., 1972; Hille, 1977; Courtney et al., 1978; Bean   
et al., 1983; Matsuki et al., 1984; Willow et al., 1985; 
Schwartz and Grigat, 1989; Butterworth and Strichartz, 
1990; Lang et al., 1993; Kuo and Bean, 1994; Xie et al., 
1995; Kuo et al., 1997; Kuo and Lu, 1997). Na
+ currents 
and cellular excitability are therefore decreased in a 
voltage- and time-dependent fashion. A common recep-
tor  for  these  drugs  has  long  been  implicated  (Kuo, 
1998a; Kuo et al., 2000; see also Ragsdale et al., 1996), 
but the exact location of the drug receptor, as well as 
the gating conformational changes essential for drug 
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receptor  modulation,  remains  unsettled.  Point  muta-
tion studies suggested that F1764 (Nav1.2 numbering) 
near the middle of the sixth transmembrane segment 
(S6) in domain 4 (D4S6) is crucial for the binding of 
both  local  anesthetics  and  anticonvulsants  (Ragsdale   
et al., 1994, 1996; McNulty et al., 2007). Similar findings 
have also been documented for the S6s in the other do-
mains (Yarov-Yarovoy et al., 2001, 2002). These findings 
led to a proposal of an internal location of the drug re-
ceptor. Unfortunately, most of the aforementioned mu-
tations also cause gating changes (Ragsdale et al., 1994; 
Yarov-Yarovoy et al., 2001; unpublished data), raising a 
concern of allosteric rather than direct modification of 
the drug receptor by mutations. On the other hand, 
there are also experimental evidences indicative of an 
external site for drug binding. For instance, functional 
The external pore loop interacts with S6 and S3-S4 linker in domain 4 
to assume an essential role in gating control and anticonvulsant action 
in the Na
+ channel
Ya-Chin Yang,
1 Jui-Yi Hsieh,
2 and Chung-Chin Kuo
2,3
1Department of Life Science, Chang-Gung University, Tao-Yuan 333, Taiwan
2Department of Physiology, National Taiwan University College of Medicine, and 
3Department of Neurology, National Taiwan 
University Hospital, Taipei 100, Taiwan
Carbamazepine, phenytoin, and lamotrigine are widely prescribed anticonvulsants in neurological clinics. These 
drugs bind to the same receptor site, probably with the diphenyl motif in their structure, to inhibit the Na
+ chan-
nel. However, the location of the drug receptor remains controversial. In this study, we demonstrate close proxim-
ity and potential interaction between an external aromatic residue (W1716 in the external pore loop) and an 
internal aromatic residue (F1764 in the pore-lining part of the sixth transmembrane segment, S6) of domain   
4 (D4), both being closely related to anticonvulsant and/or local anesthetic binding to the Na
+ channel. Double-
mutant cycle analysis reveals significant cooperativity between the two phenyl residues for anticonvulsant binding. 
Concomitant F1764C mutation evidently decreases the susceptibility of W1716C to external Cd
2+ and membrane-
impermeable methanethiosulfonate reagents. Also, the W1716E/F1764R and G1715E/F1764R double mutations 
significantly alter the selectivity for Na
+ over K
+ and markedly shift the activation curve, respectively. W1716 and 
F1764 therefore very likely form a link connecting the outer and inner compartments of the Na
+ channel pore (in 
addition to the selectivity filter). Anticonvulsants and local anesthetics may well traverse this “S6 recess” without 
trespassing on the selectivity filter. Furthermore, we found that Y1618K, a point mutation in the S3-4 linker (the 
extracellular extension of D4S4), significantly alters the consequences of carbamazepine binding to the Na
+ chan-
nel. The effect of Y1618K mutation, however, is abolished by concomitant point mutations in the vicinity of Y1618,   
but not by those in the internally located inactivation machinery, supporting a direct local rather than a long-range 
allosteric action. Moreover, Y1618 could interact with D4 pore residues W1716 and L1719 to have a profound effect 
on both channel gating and anticonvulsant action. We conclude that there are direct interactions among the ex-
ternal S3-4 linker, the external pore loop, and the internal S6 segment in D4, making the external pore loop a piv-
otal point critically coordinating ion permeation, gating, and anticonvulsant binding in the Na
+ channel.
© 2009 Yang et al.  This article is distributed under the terms of an Attribution–Noncom-
mercial–Share Alike–No Mirror Sites license for the first six months after the publication 
date (see http://www.jgp.org/misc/terms.shtml). After six months it is available under a Cre-
ative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as 
described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
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the Na
+ channel. We found that the common drug re-
ceptor should involve both W1716 in the external pore 
loop (SS6) and F1764 in the internal pore compart-
ment of S6 in domain 4. The interaction between these 
two phenyl residues constitutes a “recess” that makes a 
second link in addition to the selectivity filter between 
the inner and outer compartments of the pore. We fur-
ther demonstrated the close proximity and interaction 
between D4S3-4 linker and SS6 external pore segment, 
constituting an imperative element closely related to 
channel activation, inactivation, and the anticonvulsant 
drug action. We conclude that the D4SS6 pore loop 
segment is in a pivotal position coordinating major physi-
ological attributes (activation, inactivation, and ion per-
meation) as well as pharmacological modulations (the 
receptor for anticonvulsants and local anesthetics) of the 
Na
+ channel chiefly via its intimate interactions with 
the D4S6 segment and the D4S3-4 linker.
M AT E R I A L S   A N D   M E T H O D S
Molecular biology and expression of Na
+ channels
The plasmid pNa200 encoding the rat brain type IIA (RIIA) Na
+ 
channel was provided by A.L. Goldin (University of California,   
Irvine, Irvine, CA). The RIIA (Nav1.2) channel is chosen for the 
correlation of our data with those previously documented in na-
tive Na
+ channels in rat central neurons. Side-directed mutagene-
sis in the RIIA Na
+ channel was performed with the QuikChange 
mutagenesis system (Agilent Technologies). The mutation-con-
taining pNa200 was linearized with NotI restriction enzyme, and 
RNA transcripts for oocyte expression were synthesized using the 
T7 mMESSAGE mMACHINE transcription kit (Applied Biosys-
tems). Mature female Xenopus laevis frogs were maintained and 
handled under the supervision of National Taiwan University Col-
lege of Medicine and College of Public Health Institutional Ani-
mal Care and Use Committee. For oocyte isolation, the animals 
were anaesthetized and the ovarian sacs were removed. The frogs 
were allowed to recover in a water tank at room temperature im-
mediately after the surgery. Isolated and defolliculated oocytes 
(stages V–VI) were injected with cRNA transcripts and maintained 
at 18°C for 1–7 d before electrophysiological studies.
Two-electrode intracellular recording
Macroscopic Na
+ currents in oocytes were recorded by a standard 
two-microelectrode voltage clamp method. The oocyte was put in 
a chamber continuously perfused with modified ND-96 solution 
(in mM: 96 NaCl, 4 KCl, 1 MgCl2, 0.3 CaCl2, and 5 HEPES, pH 
7.6). 2-aminoethyl-methanethiosulfonate (MTSEA), ethylsulfonate-
methanethiosulfonate (MTSES), and ethyltrimethylammonium-
methanethiosulfonate  (MTSET;  Toronto  Research  Chemicals) 
were stocked at 70°C and dissolved in water to make 100 mM of 
aqueous stock solution that was freshly prepared daily, stored at 
20°C, and diluted immediately before use. Both voltage-sensing 
and current-passing electrodes were filled with 3 M KCl and had a 
serial  resistance  of  0.1–0.4  MΩ.  Membrane  potential  was  con-
trolled by a two-electrode voltage clamp amplifier with a virtual 
ground circuit (model OC-725C; Warner Instrument). Data were 
recorded at room temperature of 25°C and digitized at 20–100-µs 
intervals  using  a  Digidata-1200  analogue/digital  interface  and 
pCLAMP software (MDS Analytical Technologies). All statistics 
are given as mean ± SE of mean. To plot the inactivation curves, 
the oocyte was held at 120 mV and stepped to the inactivating 
data with intracellular application of phenytoin, carba-
mazepine, and lamotrigine suggest that the anticonvul-
sants should bind to the external side of the cell (Kuo, 
1998a). Moreover, point mutations of the external resi-
dues (e.g., in the external part of D4S6 or in the D4 ex-
ternal pore loop, the latter being equivalent to W1716 
in Nav1.2) would significantly alter the access of exter-
nal QX-314 and local anesthetics binding to the chan-
nel pore (Ragsdale et al., 1994; Qu et al., 1995; Wang   
et al., 1998; Lee et al., 2001; Tsang et al., 2005). Binding 
assays of [
3H]BW202W92 of the lamotrigine family also 
support an external binding site for the anticonvulsants 
(Riddall et al., 2006). Most intriguingly, occupancy of 
the external pore mouth of Na
+ channels by external 
Na
+ would delicately alter the local geometry to make 
diclofenac (a structural analogue of carbamazepine and 
also an inactivation stabilizer of the channel) an oppor-
tunistic blocker of the pore (Yang and Kuo, 2005). Con-
sistently, Tikhonov and Zhorov (2007) also proposed 
that occupation of the DEKA ring by Na
+ would antago-
nize binding of local anesthetics. These latter findings 
strongly suggest significant interaction between the ex-
ternal pore loop and the binding site for local anesthet-
ics and anticonvulsants, and thus an external location 
of the binding site in the Na
+ channel.
We have suggested that there are continuous confor-
mational changes of the anticonvulsant receptor with 
Na
+ channel activation and inactivation (Yang and Kuo, 
2002, 2005). However, how the anticonvulsant receptor 
is “shaped” with the voltage-dependent gating process 
remains obscure. Intuitively, the linkers directly con-
nected to S4s could be responsible for transducing 
membrane voltage to the conformational changes of 
the channel gates and the drug receptor. If the anticon-
vulsant receptor is in the internal part of the pore and 
formed by S6, it is conceivable that the possible inter- 
and intra-subunit interactions between the S4-S5 linker 
and the S6 in the K
+ and Na
+ channels may play a role in 
the  modulation  of  receptor  conformation  (McPhee   
et al., 1995, 1998; Tang et al., 1996; Popa et al., 2004; 
Long et al., 2005a,b). If the receptor is in the external 
vestibule, it would be interesting to note that S4 would 
move close to the external pore region in K
+ channels 
(Li-Smerin and Swartz, 2000; Elinder et al., 2001; Gandhi 
et al., 2003; Laine et al., 2003). A recent study also pro-
posed that the S3-S4 linker of domain 2 is in close prox-
imity to the pore loop of domain 3 in Nav1.4 channel 
(Cohen et al., 2007). Moreover, mutations or pore 
blockers in the external vestibule have been repeatedly 
reported to affect activation and inactivation in K
+  
and Na
+ channels (Tomaselli et al., 1995; Kuo, 1998b; 
Townsend and Horn, 1999; Hilber et al., 2001; Kuo et al., 
2004). In the present study, we propose a solution to the 
apparently perplexing or even conflicting reports on 
the location of the drug receptor and provide novel 
structural insight into the molecular organization of     Yang et al. 97
creases the affinity of carbamazepine to the inactivated 
Na
+  channel  (Table  I).  Double-mutant  cycle  analyses 
(Carter et al., 1984) reveal that all of the double muta-
tions  tested  (W1716A/F1764A,  W1716A/F1764C, 
W1716C/F1764A, and W1716C/F1764C) cannot have 
additive effects in terms of drug affinity changes, sug-
gesting a significant interaction between the two resi-
dues contributing to drug binding. It is interesting that 
the calculated pairwise interaction energies (Ginter) 
between a W1716 mutant and a F1764 mutant are al-
ways close to 0.35 kcal/mol (Table I), reminiscent of a 
recent finding of the interaction energies between aro-
matic side chains in OmpA channel (a gated channel 
from Escherichia coli; Hong et al., 2007).
The inactivation-stabilizing effect and the external Cd
2+ 
sensitivity of W1716C are abolished by mutation F1764C
In addition to the non-additive effect on drug affinity 
change, there are also interesting alterations in the gat-
ing curves of the forgoing double-mutant channels. The 
gating  curves  of  W1716C,  F1764C,  and  W1716C  plus 
F1764C (W1716C/F1764C) mutant channels are com-
pared in Fig. 1 A. The activation and inactivation curves 
in F1764C mutant channels are similar to the wild-type 
curves (with a difference in V1/2 of no more than 5 mV 
in both cases), implying that channel gating remains 
largely unaffected with the mutation. On the other hand, 
W1716C mutation evidently shifts the inactivation curve 
by 10 mV without significantly altering the activation 
curve (Fig. 1 A). Interestingly, the left shift of the inactiva-
tion curve by W1716C is “corrected” by the concomitant 
mutation F1764C (Fig. 1 A, right), again implying a sig-
nificant interaction between the two residues. Despite 
the restored inactivation properties, the W1716C/F1764C 
double mutation still significantly affects the action of the 
inactivation stabilizer carbamazepine (Table I). The drug 
pulse (for the pulse duration, see figure legends). The peak cur-
rent elicited by a test pulse to 0 mV for 10 ms after each inactivat-
ing pulse is normalized to the peak current with an inactivating 
pulse at 120 mV and plotted against the voltage of the inactivat-
ing pulse (V) to obtain the inactivation curves. The data are fitted 
with a Boltzmann function 1/(1 + exp((VV1/2)/k)), where V1/2 
is the half-inactivating potential and k is the slope factor. To plot 
the activation curves (i.e., the normalized conductance–voltage 
curves), the oocyte was stepped to different test voltages from a 
holding potential of 120 mV to obtain the current–voltage plot. 
The maximal conductance is determined by a regression line of 
the data points between the largest inward current and the zero-
current point of the current–voltage plot. The current–voltage 
plot is normalized to this regression line to give the normalized 
conductance–voltage  curve,  which  is  fitted  with  a  Boltzmann 
function 1/(1 + exp((V1/2V)/k)). V1/2 is the half-activating po-
tential and k is the slope factor.
R E S U LT S
Point mutations of W1716 and F1764 decrease the affinity 
of carbamazepine to the inactivated Na
+ channel in a non-
additive manner
We have demonstrated that anticonvulsants phenytoin, 
carbamazepine, and lamotrigine bind to a common re-
ceptor with their shared diphenyl structural motif (Kuo, 
1998a; Kuo et al., 2000). In this regard, it is intriguing 
that an external aromatic residue W1716 and an inter-
nal aromatic residue F1764 (Nav1.2 numbering) were 
both reported to affect the apparent binding affinities 
of anticonvulsants and/or local anesthetics (Ragsdale   
et al., 1994, 1996; Tsang et al., 2005; McNulty et al., 
2007). We thus examined possible interactions between 
the two residues. The binding affinity of carbamazepine 
to the inactivated channel (relative to that to the resting 
channel) was characterized by a shift of the inactivation 
curve (Bean et al., 1983; Bean, 1984). Mutation of W1716 
or F1764 into either alanine or cysteine evidently de-
TA B L E   I
Decrease of the relative binding affinity of carbamazepine to the inactivated Na
+ channel by W1716 and/or F1764 mutations
Decrease in V1/2 shift (mV) G (meV) G (Kcal) Ginter (Kcal)
F1764A 4.8 ± 0.36 20 0.46
F1764C 4.3 ± 0.76 17.9 0.41
W1716A 0.75 ± 0.29 3.2 0.074
W1716C 4.0 ± 0.72 16.7 0.38
F1764A + W1716A 1.8 ± 0.15 7.5 0.17 0.36
F1764A + W1716C 5.0 ± 0.049 20.9 0.48 0.36
F1764C + W1716A 1.2 ± 0.19 5 0.12 0.36
F1764C + W1716C 4.7 ± 0.065 19.6 0.45 0.34
The inactivation curves were done by the protocols described in Materials and methods and are fitted with a Boltzmann function 1/(1 + exp((VV1/2)/k)). 
For the sake of simplicity, we fixed the slope factor k to determine the shift of V1/2 (the difference between V1/2 values in the presence and absence of 
100 µM carbamazepine). This simplification seems to be appropriate, as the slope of the curve does not greatly differ among these mutations either in 
the presence or absence of carbamazepine. V1/2 shift of the wild-type channel is 6.1 ± 0.2 mV. The decrease in V1/2 shift by mutation is then given as the 
difference between the shift in each mutant and 6.1 mV. The free energy change (G) is directly derived from the product of the decrease in V1/2 shift 
and the apparent equivalent gating charges (derived from RT/Fk or 25 mV/k). The interaction energy Ginter is equal to the G in the double mutant 
minus the summation of G in each component single mutant. All of the Ginter values are significantly smaller than zero, strongly suggesting the non-
additive nature for W1716 and F1764 mutations to alter the drug binding affinity.98 EXTERNAL PORE LOOP SHAPES GATING AND ANTICONVULSANT BINDING IN NA
+ CHANNELS
mutations I1575C, F1579C, and V1583C in the skeletal 
muscle Na
+ channel (equivalent to I1760, F1764, and 
V1768 in Nav1.2 and presumably facing the same side in 
the S6 -helix) could not be effectively modified by sat-
urating concentrations (2 mM) of MTSET (Vedantham 
and Cannon, 2000; Sunami et al., 2001, 2004). W1716C 
thus should indeed face the external part of the pore, 
whereas F1764C is not accessible to MTSET from the 
outside. In this regard, it is interesting that the rate, 
and even more dramatically the steady-state extent, of 
MTSET modification of W1716C is decreased by the con-
comitant mutation F1764C (Fig. 2, B and C). Also, the 
state-dependent modification by MTSET is less obvious 
in the W1716C/F1764C double-mutant channel com-
pared with the single W1716C mutant channel (i.e., the 
inhibition is equally small in the double-mutant chan-
nel at 35 and 110 mV, but is much stronger at 35 
than at 110 mV in the W1716C single-mutant chan-
nel; unpublished data). These findings strongly support 
an altered local conformation or reactivity of the cyste-
ine side chain at position 1716 in the concomitant pres-
ence of the other cysteine at position 1764. In contrast 
to the case of MTSET, we found that F1764C is modifi-
able  by  external  MTSEA,  a  usually  uncharged  agent 
with a smaller size than that of MTSET (not depicted). 
However, MTSEA decreases only the late sustained phase 
(not the peak) of the current, suggesting an altered chan-
nel inactivation rather than a blocking of the passage of 
affinity changes characterized in Table I thus are unlikely 
ascribable to altered channel inactivation. Because both 
local anesthetics and anticonvulsants are pore blockers of 
the Na
+ channel, the key ligands responsible for drug 
binding should be capable of facing the pore. In this 
regard, W1716C, an additional cysteine in the external 
pore loop, indeed greatly increases the affinity of external 
pore blocker Cd
2+ to the channel (Fig. 1 B). Interestingly, 
the increase of Cd
2+ affinity with W1716C mutation is 
again largely abolished by the addition of a second cyste-
ine substitution for F1764. It is apparently counterintui-
tive that one more cysteine in the pore would lead to less 
Cd
2+ block of the channel. This finding is, however, con-
sistent with a direct or allosteric interaction between the 
two added cysteines (W1716C and F1764C), altering the 
local geometry of W1716C and consequently its sensitivity 
to external Cd
2+.
F1764C abolishes the accessibility of W1716C to different 
external MTS derivatives
We further tested the sensitivity of W1716C to different 
hydrophilic MTS reagents and examined whether it can 
also be influenced by manipulation of F1764 (Fig. 2). 
Fig. 2 A shows that the W1716C channel, but not the 
F1764C channel, can be modified by externally applied 
MTSET, a positively charged sulfhydryl reagent, at mod-
erately depolarized membrane potentials such as 35 mV. 
These findings are consistent with the report that point 
Figure 1.  The gating curves and Cd
2+ 
block in the W1716C/F1764C (WCFC) 
double-mutant and the corresponding 
single-mutant channels. (A) The activa-
tion curves (left) and the inactivation 
curves (right) were documented by the 
protocols  described  in  Materials  and 
methods. The duration of the inactivat-
ing pulse for plotting the inactivation 
curve is set at 5 s to facilitate compari-
son with the data (Table I) in the pres-
ence of drugs that have relatively slow 
binding kinetics. The findings remain 
qualitatively  very  similar  with  100-ms 
inactivating pulses (not depicted). The 
curves in the left panel are fits with a 
Boltzmann  function  with  V1/2  values 
(in mV) of 16.9, 21.3, 15.9, and 
17.2 and k values of 4.9, 5.9, 5.7, and 
4.4 for the wild-type (WT; the gray line,   
n  =  6),  W1716C  (n  =  6),  F1764C   
(n = 17), and WCFC (n = 15) mutant 
channels, respectively. The curves in the 
right panel are fits with a Boltzmann 
function  with  V1/2  values  (in  mV)  of 
54.2, 64.6, 50.9, and 49.8 and 
k values of 4.6, 6.7, 5.1, and 6.1 for the 
WT (the gray line, n = 10), W1716C   
(n = 7), F1764C (n = 4), and WCFC (n = 14) mutant channels, respectively. (B) Cd
2+ block of different mutant channels. The oocyte was 
held at 110 mV and stepped every 3 s to a test pulse of 20 mV for 100 ms. (Left) The elicited currents in the presence (red lines) and 
absence (black lines) of 100 µM Cd
2+. (Right) The peak currents in the former are normalized to the peak current in the latter to give 
the relative current (n = 4–7).  Yang et al. 99
countercharges are introduced to these two positions. 
For example, the current amplitude is also increased by 
MTSES  modification  in  the  W1716C/F1764R  mutant 
channel, and the increase is even larger than that in the 
W1716C single mutant (Fig. 2, D and E). It seems that 
both the shorter cysteine–cysteine cross-linking and the 
much longer-range linkage via MTSES-arginine (elec-
trostatic) interactions between W1716 and F1716 are ca-
pable  of  twisting  the  position  of  W1716  and/or  the 
adjacent pore loop to a different geometry (see below).
The selectivity for Na
+ is altered by W1716E/F1764R 
double mutation
We next tested whether a salt bridge can be formed 
between F1764R and W1716E, the side-chain length of 
permeating ions. We also examined whether the acces-
sibility of W1716C to the presumably negatively charged 
agent MTSES is altered by F1764C (Fig. 2, D and E). 
MTSES-modified  W1716C  channels  represent  an  in-
crease rather than decrease in current amplitude (ex-
amined at 10 mV). Nevertheless, F1764C still decreases 
the accessibility of W1716C to MTSES, and the current 
amplitude is restored (in the W1716C/F1764C double-
mutant channel; Fig. 2, D and E). Thus, F1764C abol-
ishes the accessibility of W1716C to different external 
agents (Cd
2+, MTSET, and MTSES) regardless of their 
different  chemical  properties  and  different  mecha-
nisms of actions. Other than the cysteine–cysteine cross-
linking, the close proximity of W1716 and F1716 is also 
supported by the significant electrostatic interaction if 
Figure 2.  The effect of external MTSET 
and MTSES on the wild-type, W1716C, 
F1764C, and W1716C/F1764C (WCFC) 
or  W1716C/F1764R  (WCFR)  mutant 
channels.  (A)  The  effect  of  external 
MTSET. (Left) The sample currents 
after  0-  (black  line),  60-,  and  120-s 
(red lines) cumulative modification by 
MTSET are shown. The oocyte was ini-
tially held at 110 mV and stepped to 
10 mV for 40 ms to elicit the control 
Na
+ currents in ND-96 solution. The 
oocyte was then held at 35 mV and 
perfused with ND-96 containing 0.1 mM 
(for W1716C and WCFC mutant chan-
nels) or 1 mM (for wild-type and F1764C 
mutant  channels)  of  freshly  made 
MTSET for 30 s, after which the oocyte 
was held at 110 mV again and washed 
with control ND-96 for 30–60 s. The Na
+ 
current after modification was assessed 
by a test pulse at 10 mV. This protocol   
was  repeated  until  a  steady  state  of   
MTSET modification was reached. We 
also  repeated  the  same  experimental 
protocols  in  the  absence  of  MTS  re-
agents  and  found  no  changes  in  the 
currents before and after the protocols 
(not  depicted).  (B)  The  relative  cur-
rents are plotted against the cumulative   
time in MTSET (n = 3–4). The curves   
are  relative  current  =  0.84  ×  exp(t/ 
36.2) + 0.16 and relative current = 0.22 ×   
exp(t/32.8)  +  0.78  for  the  W1716C 
and  WCFC  mutant  channels,  respec-
tively,  where  t  denotes  the  cumulative   
time in MTSET in seconds. (C) Peak Na
+ 
currents after 90-s MTSET modification 
is normalized to control currents to give 
the relative currents (n = 3–4). (D) The 
effect of external MTSES. The oocyte was 
held at 120 mV, perfused with control 
ND-96 solution or ND-96 solution con-
taining 2 mM of freshly made MTSES, 
and stepped every 2 s to 10 mV for 100 ms to assess the Na
+ currents. A steady-state effect of MTSES is usually reached within 40 s in these 
mutant channels (not depicted). The oocyte was then washed with control ND-96 for 30–60 s and stepped to 10 mV to measure the Na
+ 
current. The Na
+ currents after 0- (black line) and 40-s (red line) cumulative modification by MTSES are superimposed. (E) Peak Na
+ cur-
rents after a 40-s MTSES modification are normalized to control currents to give the relative currents (n = 3–4).100 EXTERNAL PORE LOOP SHAPES GATING AND ANTICONVULSANT BINDING IN NA
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tween  the  SS6  pore-lining  segment  and  the  internal 
segment of the S6 helix. If so, and if the pore loop has 
a  more  flexible  secondary  structure  than  -helix  or   
-sheet, a similar interaction might be obtained in the 
adjacent residues. We thus introduced a glutamate to 
G1715, a residue next to W1716 and just external to 
A1714 of the presumable selectivity filter (i.e., the DEKA 
ring). We found that neither the G1715E single-mutant 
channel nor the G1715E/F1764R double-mutant chan-
nel  significantly  changes  the  ion  selectivity  (not  de-
picted). However, the G1715E/F1764R double mutation 
leads  to  a  dramatic  rightward  shift  in  the  activation 
curve, whereas the F1764R single mutation does not 
shift the curve significantly, and the G1715E single mu-
tation even causes a slight leftward shift (Fig. 4, left). In 
contrast, the inactivation curves of these mutant chan-
nels are essentially unchanged (with either 100-ms or   
5-s inactivating pulses; Fig. 4, right, and unpublished 
data). These findings suggest a significant interaction 
between G1715E and F1764R, causing a much more sta-
bilized resting (deactivated) than activated conforma-
tion and probably even dissociation of inactivation from 
activation, and provide further support for the close 
proximity between the pore loop and S6 in domain 4. 
Interestingly, we found that the L1719E plus F1764R 
double mutation also causes a rightward shift (10-mV 
shift) of the activation curve, but not the inactivation 
curve (not depicted). It is also intriguing that a struc-
tural twist of S6 constrained by the P loop in domain 4 
would affect activation rather than inactivation, consid-
ering that D4S6 is primarily seen as an inactivation ap-
paratus (e.g., W1716C shifts the inactivation rather than 
the activation curves; Fig. 1 A). This may imply the 
which is shorter than that of the MTSES adduct attached 
to W1716C. If W1716 faces the pore, mutations at this po-
sition may affect ion passage or even ion selectivity of the 
channel (see also Tsushima et al., 1997). We found that 
W1716C and W1716A mutations indeed shift the reversal 
potential by 20–30 mV (characterized by conventional 
two-electrode intracellular recording with ND-96 external 
solution; unpublished data), whereas the W1716E mutant 
channel has a reversal potential similar to the wild-type 
channel (different by only 5 mV; Fig. 3 A). We did not 
observe currents from the W1716R mutant channel. On 
the other hand, mutations of F1764 (e.g., F1764A, F1764C, 
and F1764E) tend to cause only relatively small change in 
the  reversal  potential  (changes  of  1–12  mV;  unpub-
lished data). Notably, the F1764R mutant channel has a 
reversal potential very similar to that of the wild-type chan-
nel (Fig. 3, A and B). Although either W1716E or F1764R 
single mutation negligibly affects the reversal potential, 
the W1716E/F1764R double-mutant channel has a very 
dramatic shift (40 mV) in the reversal potential, nearly 
abolishing the selectivity for Na
+ over K
+ (i.e., the reversal 
potential is close to 0 mV; Fig. 3 A with the oocyte bathed 
in ND-96 solution). These findings are consistent with the 
idea that that W1716 faces the pore and is closely associ-
ated with the selectivity filter. Moreover, there is very likely 
a direct and significant interaction (e.g., a salt bridge) be-
tween W1716E and F1764R, critically altering the confor-
mation of the pore loop and consequently ion selectivity.
The activation curve shows a large rightward shift  
with countercharges introduced at G1715 and F1764
The selectivity change in the W1716E/F1764R double-
mutant channel in Fig. 3 suggests close proximity be-
Figure  3.  The reversal potentials in the wild-type (WT), W1716E, F1764R, and W1716E/F1764R (WEFR) mutant channels.   
(A) The representative current–voltage plots. The oocytes expressing each of the four different channels were bathed in ND-96. The   
oocytes were held at 120 mV and stepped to a test pulse of 120 to +50 mV for 100 ms, and then returned to 120 mV. The pulse proto-
cols were repeated every 3 s, and the peak current at each test pulse is normalized to the maximal current elicited and plotted against the 
test pulse voltage to give the current–voltage plots. (B) The averaged reversal potentials for the four different channels in A (n = 5–15).  Yang et al. 101
reduction,  incompatible  with  the  actual  current  “aug-
mentation” during essentially the whole phase of current 
decay (Fig. 5 A). Second, at least in the Y1618K mutant 
channel, the binding of carbamazepine slows the kinetics 
of inactivation but still “stabilizes” the inactivated state 
over the resting state of the channel (see also Fig. 6). In 
other words, change of a presumably externally located 
aromatic residue in the D4S3-4 linker could significantly 
alter the conformation of the anticonvulsant binding site 
in the pore, and drug binding to the altered receptor 
now has a deterring effect on the operation of the inacti-
vation machinery. We found that carbamazepine also has 
a slowing effect on macroscopic current decay in the 
other mutant channels with charge-containing substitu-
tions for Y1618, such as Y1618D and Y1618R (albeit to a 
lesser extent than Y1618K; Fig. 5 B). On the other hand, 
carbamazepine accelerates the macroscopic current de-
cay when Y1618 is mutated to tryptophan (Y1618W, a 
plainer aromatic residue), but not to proline and alanine 
(Y1618P and Y1618A; Fig. 5 B; the absolute values of the 
decay rates for the wild-type and different Y1618 mutant 
channels without drugs are given in Table II). These find-
ings argue for a close and delicate association of Y1618 
with the conformation of the anticonvulsant binding site, 
and thus small differences among the substituted side 
chains at this position would so differently alter the local 
binding geometry of the anticonvulsant and consequently 
the action of carbamazepine on the channel.
Y1618K mutation probably increases the affinity  
of carbamazepine to the resting Na
+ channel
In view of the significant retardation of macroscopic inac-
tivation (Fig. 5 A), the binding of carbamazepine to the 
Y1618K mutant channel should happen before channel 
inactivation. Because of the very low affinity of carbam-
azepine to the resting wild-type Na
+ channel (Willow 
et al., 1985; Schwartz and Grigat, 1989; Kuo et al., 1997), 
involvement of the external pore loop of domain 4 in 
the coupling of channel activation and inactivation (see 
below). These findings indicate that the structural ar-
rangement in the vicinity of SS6 and the adjacent S6 is 
critical for the proper functional attributes of the Na
+ 
channel,  including  activation,  inactivation,  and  ion 
permeation.
Carbamazepine retards macroscopic inactivation  
of the Na
+ channel with mutations of an aromatic  
residue Y1618 in the S3-4 linker of domain 4
We have demonstrated that the interaction between 
D4SS6 and D4S6 in the Na
+ channel is crucial for drug 
receptor formation and appropriate channel gating, both 
being attributes closely associated with the membrane 
voltage. Because there is a tight correlation between D4S4 
and channel inactivation (Stühmer et al., 1989; Chahine 
et al., 1994; Chen et al., 1996; Kühn and Greeff, 1999; 
Sheets et al., 1999; Yang and Kuo, 2003), and the inter-
action between the “inactivation-stabilizing” anticonvul-
sants and their receptor site most likely involves the 
diphenyl structural motif (Kuo, 1998a; Kuo et al., 2000), 
we searched the aromatic amino acid residues in the re-
gions that are likely to be affected by the movement of 
the D4S4 voltage sensor. We found that lysine substitution 
for a tyrosine residue (Y1618) in the D4S3-S4 linker, a 
short extracellular extension of D4S4, would intriguingly 
alter the action of carbamazepine. As carbamazepine is 
also a pore blocker of the wild-type Na
+ channel, the mac-
roscopic current decay is significantly accelerated with a 
high concentration of the drug (Yang and Kuo, 2002). 
However, carbamazepine retards the fast decay phase of 
the macroscopic Na
+ current in the Y1618K mutant chan-
nel (Fig. 5 A). This apparently simple finding has two im-
portant implications. First, carbamazepine is no longer 
an effective pore blocker of the Na
+ channel. Otherwise, 
binding of the drug would immediately result in current 
Figure  4.  The  gating  curves  in  the 
wild-type  (WT),  G1715E,  F1764R,  and 
G1715E/F1764R (GEFR) mutant chan-
nels. The activation (left) and inactiva-
tion  curves  (right;  inactivating  pulse 
duration  =  5  s)  were  documented  by 
the protocols described in Materials and 
methods. The data for the wild-type chan-
nel are from Fig. 1 A and shown as gray 
symbols with gray lines. The activation 
curves are fits with a Boltzmann function 
with V1/2 values (in mV) of 27.2, 17.5, 
and 4.9 and k values of 3.9, 5.9, and 6.4 
for G1715E (n = 3), F1764R (n = 6), and 
GEFR (n = 7) mutant channels, respec-
tively. The inactivation curves are fits with 
a  Boltzmann  function  with  V1/2  values 
(in mV) of 54.2, 52.3, and 54.2 and   
k values of 4.3, 4.6, and 5.8 for G1715E 
(n = 6), F1764R (n = 8), and GEFR (n = 6) 
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carbamazepine should occupy only a very small frac-
tion of open channels within 1–2 ms. It is thus hard to 
envisage the manifestation and saturation of the slow-
ing of current decay at 30 µM and 100–300 µM carbam-
azepine,  respectively  (Fig.  5  C,  right).  We  therefore 
propose that carbamazepine more likely binds to the 
resting Y1618K channel to slow inactivation (also see 
below for additional evidence). If so, then the concen-
tration-dependent slowing of the decay rate in Fig. 5 C 
would signal that carbamazepine binds to the resting 
Y1618K channel with a dissociation constant (KR) of 
46 µM, a much higher affinity than that to the rest-
ing wild-type channel (>2,000 µM; Kuo et al., 1997).   
In  this  case,  carbamazepine  bound  to  the  resting 
Y1618K channel might slow down the development of 
inactivation to 38% of that in the drug-free channel 
(Fig. 5 C, right).
one would at first surmise that carbamazepine binds to 
the  activated  (open)  Y1618K  channel  to  slow  subse-
quent inactivation. Indeed, we have previously reported 
that carbamazepine binds to the open wild-type Na
+ 
channel faster than to the inactivated channel (1.10
6 
vs. 4 × 10
4 M
1s
1; Yang and Kuo, 2002). In this regard, 
because carbamazepine evidently accelerates the macro-
scopic current decay in the Y1618W channel (Fig. 5 B), 
we roughly estimated the open-channel pore-block-
ing rate of carbamazepine as 1.8 × 10
5 M
1s
1 (with 
an assumption of one-to-one binding of drug to the 
open channel; Fig. 5 C, left). However, the slowing of 
macroscopic inactivation by carbamazepine is discern-
ible slightly later than the current peak in the Y1618K 
channel (i.e., 1–2 ms after the start of the depolariz-
ing pulse; see Fig. 5 A). If a binding rate to the open 
channel is 1.8 × 10
5 to 1.10
6 M
1s
1, then 30–300 µM 
Figure  5.  Carbamazepine  action  on 
the  decay  phase  of  macroscopic  Na
+ 
currents  in  different  Y1618  mutant 
channels. (A) 300 µM carbamazepine 
(CBZ) slightly accelerates the decay of 
the macroscopic current in the wild-type 
(WT) channel but evidently slows cur-
rent decay in the Y1618K mutant chan-
nel. The two superimposed traces show 
the representative currents elicited by 
a step depolarization to +10 mV from 
a holding potential of 120 mV in the 
absence (black line) and presence (red 
line)  of  300  µM  carbamazepine.  The 
dotted line indicates zero current level. 
Note that in the Y1618K channel, the 
slowing of current decay is not discern-
ible from the peak but only becomes 
evident later on (the arrow indicates an 
arbitrary “starting point” for the slowing 
of decay). (B; Top) The same experi-
ments as those in A were repeated in 
different Y1618 mutant channels. 300 
µM carbamazepine (red lines) slightly 
slows  the  macroscopic  current  decay 
in the Y1618D and Y1618R, yet acceler-
ates the decay in the Y1618W channels. 
The dotted line indicates zero current 
level. (Bottom) The relative decay rate 
(the decay rate in 300 µM carbamaze-
pine normalized to the decay rate in 
control) is compared among different 
Y1618 mutant (Y1618K, D, R, W, P, and 
A) channels (n = 3–9). The decay rate 
is obtained from the inverse of the time 
constant of the monoexponential fit to the current decay. (C) Estimation of carbamazepine binding rate to the open Y1618W mu-
tant channels and binding affinity to the resting Y1618K mutant channels. (Left) The differences between the inverses of the current 
decay time constants in drug and in control are plotted against the concentration of carbamazepine in the Y1618W mutant channel   
(n = 3). The line is the linear regression fit to the data points of the form: blocking rate (s
1) = 0.177 × D + 8, where D is the concentra-
tion of carbamazepine in µM. The slope of the line (1.8 × 10
5 M
1s
1) gives a rough estimate of the binding rate of carbamazepine to 
the open Y1618W channel. (Right) The relative decay rates of the Y1618K mutant channel are plotted against different concentrations 
of carbamazepine. The relative decay rates in 30, 100, and 300 µM carbamazepine are 0.78 ± 0.028, 0.55 ± 0.046, and 0.48 ± 0.023, respec-
tively (n = 4–9). The error bars are omitted in the plot. The curve is the fit of the data points with a one-to-one binding function: relative 
decay rate = (1 + 0.38 × D/46.4)/(1 + D/46.4), where D is the concentration of carbamazepine in µM.  Yang et al. 103
by the Y1618 mutation. Similar to carbamazepine, phe-
nytoin and lamotrigine also produce a much smaller 
shift of the inactivation curve shift in the Y1618K mu-
tant channel than in the wild-type channel (Fig. 6 B). 
The altered gating conformational changes in the drug 
receptor  with  the  D4S3-4  linker  mutations,  together 
with the different configurations of drug binding in 
the ion permeation pathways (Fig. 5), would strongly 
implicate  a  close  relationship  among  the  D4S3-S4 
linker, the pore region, and the gating machinery of the 
Na
+ channel.
The macroscopic inactivation of the Y1618K mutant 
channel is slowed to different extents by different 
anticonvulsant drugs
Although the altered shifts in the inactivation curve are 
very similar among all three anticonvulsants, different an-
ticonvulsants have different slowing effects on the macro-
scopic inactivation of the Y1618K channel (Fig. 7 A). At a 
concentration of 100 µM, for example, carbamazepine is 
the most effective to slow current decay. Phenytoin has a 
smaller effect, whereas lamotrigine (up to 1 mM) has 
only a negligible effect in this regard. On the other hand, 
diclofenac, an antiinflammatory drug that also contains 
the common diphenyl structure and presumably binds to 
the same receptor of the anticonvulsants (Yang and Kuo, 
2005),  also  has  an  inactivation-slowing  action  roughly 
comparable to phenytoin. Even in the highest concentra-
tion up to the solubility limits, diclofenac, phenytoin, and 
lamotrigine cannot produce the same extent of inactiva-
tion slowing as 100 µM carbamazepine does. Carbamaze-
pine, which contains the most constrained diphenyl motif 
in a dibenzazepine structure (Kuo et al., 2000), probably 
most effectively “abducts” the binding ligands in the anti-
convulsant receptor to a specific configuration to inter-
fere (kinetically) with the inactivation machinery, whereas 
lamotrigine, which contains a shortest center-to-center 
distance between the two phenyl groups (Kuo et al., 
2000), is the least capable of doing so. These findings 
again argue for a very local and direct effect of  Y1618 mu-
tations on channel gating.
Charged substitutions for Y1618 produces a smaller shift 
of the inactivation curve by carbamazepine and the other 
anticonvulsants
It is well established that carbamazepine and the other 
anticonvulsants  preferentially  bind  to  the  inactivated 
rather than the resting wild-type Na
+ channel. If carba-
mazepine significantly binds to the resting Y1618K chan-
nel, it would be desirable to examine the relative binding 
affinity of the anticonvulsants to the resting versus inac-
tivated Y1618 channels. Fig. 6 A shows an evidently smaller 
shift of the inactivation curve by 300 µM carbamazepine 
in the Y1618K, Y1618D, or Y1618R mutant channel than 
that in the wild-type channel, as if the relative binding 
affinity of drug to the inactivated over the resting chan-
nel is significantly decreased by the charged mutations 
at Y1618. On the other hand, with the Y1618W muta-
tion, carbamazepine has a similar effect on the inactiva-
tion curve to the wild-type case. The extent of inactivation 
curve shift could be described by:
  exp  V k     1 D K 1 D K I R ( / ) / / / , ∆ = + ( ) + ( )    (1)
where V denotes the shift in mV, k is a slope factor ob-
tained from the fit of the curve with a Boltzmann func-
tion, and D is the drug concentration (Bean et al., 1983; 
Bean, 1984). According to Eq. 1 and with a KR of 46 µM 
(Fig. 4 C), the KI (the dissociation constant of drug to 
the inactivated channel) value would be 18 µM in the 
Y1618K mutant, slightly smaller than that in the wild-
type channel (25 µM; Kuo et al., 1997). These data   
indicate that charged mutations at Y1618 markedly de-
crease the differences between the binding affinity of 
carbamazepine  to  the  inactivated  and  to  the  resting 
channels, consistent with the proposal of altered recep-
tor  conformation  and  increased  drug  affinity  in  the 
resting channel. In this regard, different anticonvul-
sants presumably bind to a common receptor in the in-
activated Na
+ channel with the common diphenyl motif 
in their structure (Kuo, 1998a; Kuo et al., 2000). If mu-
tations of Y1618 do alter the local geometry of the drug 
receptor for drug binding, the shift of the inactivation 
curve by the other anticonvulsants may also be altered 
TA B L E   I I
The decay rate of the macroscopic current through the wild-type and different Y1618K mutant channels
Wild-type
Y1618 single mutants
Y1618K Y1618D Y1618R Y1618W Y1618A Y1618P
Decay rate 
(ms
−1)
0.25 ± 0.05 0.42 ± 0.02 0.78 ± 0.10 0.60 ± 0.10 0.23 ± 0.07 0.56 ± 0.01 0.28 ± 0.03
Y1618 double mutants
Y1618K + F1619K Y1618K + K1617A Y1618K + E1616K Y1618K + R1626C Y1618K + F1651A
Decay rate 
(ms
−1)
0.45 ± 0.01 0.36 ± 0.01 0.22 ± 0.02 0.21 ± 0.02 0.40 ± 0.03
The macroscopic current is elicited by a step depolarization to +10 mV from a holding potential of 120 mV. The decay phase of the elicited current is 
fitted with a monoexponential function, and the inverse of the current decay time constant is given in the table (n = 3–19).104 EXTERNAL PORE LOOP SHAPES GATING AND ANTICONVULSANT BINDING IN NA
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completely abolish the effect of  Y1618K mutation on the 
action of carbamazepine. For example, in the Y1618K/
F1619K, Y1618K/K1617A, or Y1618K/E1616K double-
mutant channels, carbamazepine can no longer slow the   
macroscopic inactivation (Fig. 7 B). Even a concomitant   
mutation (R1626C) at the outermost arginine of S4 (i.e., 
at the junction between the S3-4 linker and S4) also ef-
fectively wipes out the inactivation-slowing effect of car-
bamazepine on the Y1618K channel. On other hand, 
concomitant mutation at the presumable intracellular 
inactivation machinery, such as F1651A in the D4S4-5 
linker (McPhee et al., 1998), well keeps the inactivation-
slowing effect of carbamazepine made by Y1618K. In this 
Concomitant mutations of the S3-4 linker residues close 
to Y1618 rather than those far away in the intracellular 
inactivation machinery abolish the inactivation-slowing 
effect of carbamazepine on Y1618K
We next examined whether other residues in the D4S3-
4 linker could also affect the local conformation of the 
anticonvulsant receptor. Except for those mutations 
involving Y1618, we did not find any other point muta-
tions (e.g., E1616K, K1617A, and F1619K) in the S3-S4 
linker to have the inactivation-slowing effect by carba-
mazepine (see the F1619K current shown in Fig. 7 B as   
an example). However, concomitant substitutions of   
the residues nearby Y1618 in the S3-S4 linker could 
Figure  6.  Comparison  of  the  shift 
of  the  inactivation  curve  by  carbam-
azepine and the other anticonvulsant 
drugs  in  the  wild-type  and  different 
Y1618  mutant  channels.  The  inacti-
vating pulse duration was 9 s to make 
sure  of  steady-state  binding  of  the   
anticonvulsants, which have relatively 
slow binding rates onto the channel.   
(A) Representative inactivation curves 
in different Y1618 mutant channels be-
fore (open circles) and after (closed 
circles) the application of 300 µM car-
bamazepine. The lines are fits with a 
Boltzmann  function  with  V1/2  values 
(control vs. 300 µM carbamazepine) in 
mV of 54.4 versus 64.9, 62.2 ver-
sus 66.1, 71.5 versus 75.5, 54.7 
versus 60.6, and 62.0 versus 74.6, 
and  k  values  (control  vs.  carbamaze-
pine) of 4.3 versus 4.5, 5.7 versus 5.7, 
5.4 versus 5.7, 5.0 versus 8.3, and 4.5 ver-
sus 5.2 for the wild-type (WT), Y1618K, 
Y1618D, Y1618R, and Y1618W mutant 
channels, respectively. The shift (V) 
of the inactivation curve is defined as 
the difference between the V1/2 values 
in 300 µM carbamazepine and the V1/2 
value  in  control  and  is  shown  in  the 
bar graph. Mutations Y1618K, Y1618D, 
and Y1618R, but not Y1618W, evidently 
decrease  the  shift  of  the  inactivation 
curve by carbamazepine (n = 3–4). ***, 
P < 0.005 by Student’s t test (compared 
with the wild-type data). (B) The shift 
of the inactivation curve by phenytoin 
and lamotrigine in the Y1618K mutant 
channel. The top panels show two rep-
resentative oocytes containing the wild-
type  channel  (left)  and  the  Y1618K 
mutant  channel  (right),  respectively. 
In  the  Y1618K  mutant  channel,  the 
leftward shift of the inactivation curve 
by 100 µM lamotrigine (LMT), 100 µM 
phenytoin (DPH), or 300 µM carbam-
azepine (CBZ) is evidently smaller than that in the wild-type channel. Two sets of control data (control I and II, respectively; open sym-
bols) were obtained before and after drug application in each plot to show no voltage drift during this long experiment. The lines are 
fits with a Boltzmann function. The averaged shift (V) of the inactivation curve by 100 µM lamotrigine, phenytoin, or carbamazepine 
is shown in the bar graph (n = 4–5). **, P < 0.05 and ***, P < 0.005 by Student’s t test (compared with the wild-type data with 100 µM 
carbamazepine).  Yang et al. 105
Cd
2+ and Zn
2+ interaction with the Y1618H plus W1716H 
double mutation reveals close proximity between S3-4 
linker and SS6 pore-lining segment in domain 4
We have argued that there is a delicate interaction be-
tween Y1618 in the S3-4 linker and the common anti-
convulsant receptor presumably in the external pore 
mouth. We have also seen in Figs. 1–4 that W1716 very 
likely interacts with F1764 to be responsible for the drug 
receptor and proper ion permeation. To explore possi-
ble interaction between Y1618 and W1716, we initially 
made  Y1618K/W1716E  and  Y1618C/W1716C  double 
regard, it is especially noted that the apparent macro-
scopic currents are similar in the Y1618K/R1626C and 
Y1618K/F1651A double-mutant channels (both having 
partially impaired inactivation; see representative cur-
rents in Fig. 7 B). These findings further substantiate 
a very local effect of Y1618 mutation on the altera-
tion of drug binding geometry. It is also notable in the 
Y1618K/F1651A double-mutant channel that, despite 
the slowed inactivation kinetics by carbamazepine, the 
drug still stabilizes the inactivation state that is partially 
impaired by F1651A (Fig. 7 B, inset).
Figure  7.  Delicate  effects 
of  drug  structure  and  local 
conformation around Y1618 
on the slowing of the mac-
roscopic  current  decay  in   
the Y1618K mutant channel.   
(A) The experiments and plots 
are done in the Y1618K mu-
tant  channel  with  the  same 
methods  described  in  Fig.  5, 
except  that  different  con-
centrations of different anti-
convulsants  were  applied. 
The macroscopic currents re-
corded in the presence (red 
lines)  and  absence  (black 
lines) of drugs are superim-
posed.  The  slowing  effects 
on  the  macroscopic  current 
decay  by  100  µM  carbam-
azepine, 100 µM phenytoin,   
and 300 µM diclofenac are 
discernible.  However,  la-
motrigine,  even  at  1  mM, 
only  has  a  negligible  effect 
on the decay. The dotted line 
indicates  zero  current  level. 
The relative decay rates (the 
decay rate in drug relative to   
that in control) in the Y1618K 
mutant channel are shown in 
the  bar  graph  for  different 
concentrations  of  different 
drugs (n = 3–9). (B) The ef-
fect  of  concomitant  muta-
tions of  another  residue  in 
the  D4S3-4  linker  or  in  the 
D4S4-5 linker on the slowed 
macroscopic current decay by 
carbamazepine in the Y1618K 
mutant  channel.  The  mac-
roscopic  currents  recorded 
in the presence (red lines) 
and absence (black lines) of   
300 µM carbamazepine are 
superimposed. In the F1619K 
single-mutant and the Y1618K plus F1619K, K1617A, E1616K, or R1626 double-mutant channels, 300 µM carbamazepine shows no slow-
ing effect on the macroscopic current decay. On the other hand, in the Y1618K/F1651A double-mutant channel, carbamazepine still 
slows the development of the partially impaired inactivation (ascribable to F1651A mutation). In this case, however, carbamazepine still 
helps to stabilize inactivation and reduces the sustained current at the end of a prolonged depolarizing pulse (e.g., 2 s; the inset figure). 
The dotted line indicates zero current level. (Right) The macroscopic decay rate in 300 µM carbamazepine is normalized to that in 
control to obtain the relative decay rate in different mutant channels (n = 3–9).106 EXTERNAL PORE LOOP SHAPES GATING AND ANTICONVULSANT BINDING IN NA
+ CHANNELS
The altered gating curves and carbamazepine action 
suggest close proximity between Y1618 and L1719  
in the pore loop
The findings in Fig. 8 suggest close proximity between 
Y1618 in the S3-4 linker and W1716 in the pore loop of 
domain 4. To investigate the other potential interac-
tions between Y1618 and the external pore loop resi-
dues in domain 4, we did “glutamate screening” of the 
residues in the vicinity of W1716, i.e., those in the D4 
pore loop external to the presumable selectivity filter 
residue  (A1714  of  the  DEKA  ring).  With  glutamate 
substitutions  for  the  pore  residues  G1715  through 
L1720  (except  D1717,  which  itself  is  a  negatively 
charged residue and was therefore mutated to ala-
nine), we found no significant changes in the activa-
tion  and  inactivation  curves  of  these  single-mutant 
channels (not depicted). However, when these gluta-
mate substitutions are made with Y1618K, the inactiva-
tion curve is specifically shifted to the left by 30 mV 
in the Y1618K/L1719E double-mutant channel, in con-
trast with a much smaller change in the activation curve 
(Fig. 9, A and B). To verify the electrostatic interaction 
between the countercharges, we did reverse mutations 
at Y1618 and L1719. There is no observable current 
mutations, but did not observe any discernible currents. 
We then took an alternative approach and introduced 
histidine substitutions for Y1618 and/or W1716. Fig. 8 
shows the effect of externally applied group IIB divalent 
cations, namely Cd
2+ and Zn
2+, on these mutant channels. 
The  channel  pore  does  not  seem  to  be  significantly 
blocked by 100–300 µM Cd
2+ and Zn
2+ in these mutant 
channels (e.g., slightly decreased peak current without 
evident acceleration of current decay by Cd
2+ or Zn
2+). 
However, the macroscopic activation kinetics is signifi-
cantly retarded by both Cd
2+ and Zn
2+ in the Y1618H/
W1716H double mutant, but not in either component 
single-mutant  channels  (i.e.,  Y1618H  or  W1716H;   
Fig. 8 A). Moreover, the activation curve of the Y1618H/
W1716H double-mutant (but not of either single-mu-
tant) channel is dramatically shifted to the right on the 
voltage axis by Cd
2+ and Zn
2+ (Fig. 8 B). These findings 
indicate a metal-chelating site formed by close proxim-
ity of the two histidine residues. Also, because domain   
4 is primarily considered a structure specialized for   
Na
+ channel inactivation, it is highly interesting that   
the binding of non-permeating divalent cations onto 
Y1618H/W1716H  should  dramatically  affect  channel 
activation (see below).
Figure 8.  The effect of external group 
IIB  divalent  cations  on  the  Y1618H, 
W1716H,  and  Y1618H  plus  W1716H 
mutant  channels.  (A)  The  represen-
tative  currents  in  the  absence  (solid 
black lines) and presence of 100 µM 
Cd
2+  (green  lines)  and  300  µM  Zn
2+ 
(red lines) on the same oocyte. The oo-
cyte was held at 120 mV and stepped 
to 10 mV to elicit Na
+ currents. The 
pulse protocol was repeated every 3 s 
until a steady-state effect of Cd
2+ or Zn
2+ 
was reached. The effects of both Cd
2+ 
and  Zn
2+  can  be  readily  washed  out 
with the control ND-96 solution, and 
the observed effect remains the same 
regardless of the order of Cd
2+ and Zn
2+ 
application. The dotted lines mark the 
zero current level. (B) The activation   
curves  in  the  absence  (open  circles 
and solid black lines) and presence of 
100 µM Cd
2+ (top panels; closed circles 
and green lines) or 300 µM Zn
2+ (bottom 
panels;  closed  circles  and  red  lines) 
were done by the protocols described 
in  Materials  and  methods.  The  lines 
are fits with a Boltzmann function with 
V1/2  values  (control  vs.  Cd
2+)  in  mV 
of  17.2  versus  14.2,  19.7  versus 
10.6,  and  18.6  versus  19.5,  and   
k values (control vs. Cd
2+) of 4.8 versus 
5.0, 4.9 versus 5.3, and 3.9 versus 3.8, 
and V1/2 values (control vs. Zn
2+) in mV of 16.5 versus 12.4, 19.5 versus 4.7, and 18.6 versus 16.0, and k values (control vs. 
Zn
2+) of 5.9 versus 5.8, 3.7 versus 4.2, and 3.9 versus 4.0 for the W1716H, the Y1618H plus W1716H, and the Y1618H mutant channels, 
respectively. The averaged shift of the V1/2 of the activation curve by Cd
2+ is 0.8 ± 0.2, 1.9 ± 1.0, and 8.2 ± 0.9 mV, and the averaged V1/2 
shift by Zn
2+ is 2.6 ± 1.1, 3.7 ± 2.0, and 10.7 ± 2.6 mV for the Y1618H, the W1716H, and the Y1618H plus W1716H mutant channels, 
respectively (n = 3–4).  Yang et al. 107
ally  saturated  phenomenon  may  imply  that  the  re-
tarded D4S4 movement (which is critically associated 
with channel inactivation; Yang and Kuo, 2003) by car-
bamazepine would become more rate limiting in the 
whole macroscopic inactivation process (which is cou-
pled to channel activation) at more depolarized mem-
brane potentials. The lack of voltage dependence of 
the carbamazepine effect in the Y1618K/L1719E dou-
ble-mutant channel thus suggests either significant un-
coupling of inactivation from activation or additional 
retardation  of  channel  activation  by  carbamazepine. 
The former does not seem to be the case because the 
voltage  dependence  of  the  macroscopic  inactivation 
rates in the absence of carbamazepine remains very 
similar (i.e., becoming faster and saturating with more 
depolarized potentials such as 10 to 20 mV; Fig. 10 D) 
in  all  mutant  channels,  including  Y1618K/L1719E. 
On the other hand, the latter seems plausible as we 
found that the activation curve is rightwardly shifted 
and the macroscopic activation is slowed by carbamaze-
pine  in  the  Y1618K/L1719E  double-mutant  channel 
(Fig. 10 E; note that there is no discernible change in 
activation  of  the  Y1618K  single-mutant  channel;  not 
depicted). This is consistent with the findings in Fig. 8, 
where the binding of external ligands and presumably 
a subsequent connection between the D4S3-4 linker 
and the pore loop would slow the macroscopic activa-
tion rate and shift the activation curve. This prominent 
action of carbamazepine on channel activation is also 
consistent with the idea of significant binding of carba-
mazepine to the resting Y1618K mutant channel. It is 
plausible  that  the  altered  interaction  between  the 
D4S3-4 linker and D4 pore loop may allow a partially 
extruded D4S4 position (Fig. 9) even in the “resting” 
channel, to which carbamazepine may bind to retard 
from  the  Y1618E  mutant  channel,  but  the  Y1618D/
L1719K double mutation also has a prominent effect 
on the gating curves, very much similar to the case in 
the  Y1618K/L1719E  double  mutation.  It  should  be 
noted that not any corresponding component single 
mutation  here  (i.e.,  Y1618K,  L1719E,  Y1618D,  and 
L1719K)  has  significant  effect  on  the  gating  curves 
(not depicted). These findings are very much reminis-
cent of the consequence of the mutations at F1625 
(located between the S3-4 linker and the S4), where 
stabilization of a presumably extruded D4S4 by differ-
ent  mutations  results  in  stabilization  of  inactivation 
(e.g., a large-scale leftward shift of the inactivation curve) 
without  alteration  in  channel  activation  (Yang  and 
Kuo, 2003). The relatively long side chains of lysine 
and glutamate (or aspartate) in Y1618K/L1719E and 
Y1618D/L1719K probably interact to stabilize the D4S4 
voltage  sensor  in  an  outwardly  translocated  position 
and  consequently  stabilize  channel  inactivation.  If 
Y1618K differentially interacts with L1719E during S4 
outward translocation, it would be interesting to see 
how the gating conformational changes in the anticon-
vulsant receptor are altered by the double mutation. 
We found that carbamazepine still retards the macro-
scopic inactivation rate in the Y1618K/L1719E double-
mutant channel at 0 mV (Fig. 10, A and B). However, 
the  Y1618K/L1719E  double  mutation  abolishes  the 
voltage  dependence  of  the  carbamazepine  effect  on 
the inactivation rate (Fig. 10 C). In the Y1618K single 
mutant as well as in Y1618K plus G1715E, G1718E, or 
L1720E  (but  not  L1719E),  double-mutant  channels, 
when the membrane voltage becomes more depolar-
ized, the inactivation slowing by carbamazepine is more 
prominent and the effect is then “saturated” at more 
positive voltages. This voltage-dependent and eventu-
Figure 9.  Alterations in the 
activation  and  inactivation 
curves by the interaction be-
tween  the  countercharges 
introduced to Y1618 and the 
pore loop residues in domain 
4.  The  averaged  activation 
curves (A) and inactivation 
curves  (B;  the  inactivating 
pulse  duration  =  100  ms) 
were  done  by  the  protocols 
described  in  Materials  and 
methods (n = 3–5). The lines 
in the left panel are fits with a 
Boltzmann function with V1/2 
values (in mV) of 24.5, 23.4, 21.4, 27.7, 20.5, and 29.7, and k values of 4.6, 4.2, 4.0, 5.2, 5.2, and 4.6 for Y1618K, Y1618K plus 
G1715E, Y1618K plus G1718E, Y1618K plus L1719E, Y1618K plus L1720E, and Y1618D plus L1719K mutant channels, respectively. The 
data for the wild-type channel are from Fig. 1 A. The lines in the right panel are fits with a Boltzmann function with V1/2 values (in mV) of 
47.2, 46.1, 48.6, 47.8, 75.0, 48.5, and 89.1, and k values of 6.0, 7.3, 6.9, 6.8, 6.7, 7.0, and 5.3 for the wild-type, 1618K, Y1618K 
plus G1715E, Y1618K plus G1718E, Y1618K plus L1719E, Y1618K plus L1720E, and Y1618D plus L1719K mutant channels, respectively. 
We also did the inactivation curves with 9-s inactivating pulses and found that the inactivation curve is still leftward shifted by 30 mV 
in the Y1618K/L1719E double-mutant channel compared with the wild-type channel. The data for the wild-type channel are shown as 
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D I S C U S S I O N
W1716 in the external pore loop is located in close 
proximity to F1764 in the internal part of S6 in domain 4  
of the Na
+ channel
Two aromatic residues, W1716 and F1764, have been 
reported to contribute to anticonvulsant binding to the 
Na
+ channel (Ragsdale et al., 1994, 1996; Tsang et al., 
2005; McNulty et al., 2007). In this study, we demon-
strate that W1716 (in the external pore loop) is located 
in close proximity to F1764 (presumably lining the in-
ternal compartment of the pore of the S6 helix). First, 
(in terms of a kinetic rather than a steady-state effect) 
further movement of D4S4 and thus the occurrence of 
channel inactivation. The capability of carbamazepine 
binding to the resting mutant channel to retard chan-
nel  activation,  together  with  the  incapability  of  the 
bound  carbamazepine  to  block  the  mutant  channel 
pore,  indicates  that  the  interaction  between  D4S3-4 
linker and D4 pore loop is a critical pivotal point be-
tween channel gating and ion permeation, very likely 
playing an imperative role in both the state-dependent 
conformational changes in the anticonvulsant receptor 
and the activation-inactivation coupling.
Figure  10.  Carbamazepine  action 
on  the  mutant  channels  containing 
Y1618K and glutamate substitutions for   
the  pore  loop  residues  in  domain  4.   
(A) The two superimposed traces show 
the representative currents elicited from 
a holding potential of 120 mV to a   
test depolarization at 0 mV in the ab-
sence (black lines) and presence (red 
lines) of 300 µM carbamazepine. The 
dotted line indicates zero current level. 
(B) The macroscopic current decays in A 
are quantified by the methods in Fig. 1 D   
to  give  the  relative  decay  rates  for   
different mutant channels (n = 3–4). 
(C) The relative decay rates of the mac-
roscopic currents (in 300 µM carbam-
azepine vs. in control) are examined at 
different test voltages and in different 
mutant channels (n = 3–4 for each dif-
ferent channel). Note the apparent lack 
of voltage dependence of the data from 
the  Y1618K/L1719E  double-mutant 
channel. (D) The decay time constants 
(in ms) of the macroscopic currents in 
control (i.e., without any drug) are plot-
ted against different test voltages in dif-
ferent mutant channels (n = 4 for each 
different channel). The mutant chan-
nels in the figure all have significantly 
faster  saturating  inactivation  kinetics 
than the wild-type channel. The decay 
time constants examined at +10 mV for 
the mutant channels are all ranged be-
tween 1.4 ± 0.26 and 2.4 ± 0.41 ms, and 
that for the wild-type channel (n = 9) 
is 4.1 ± 0.83 ms (P < 0.001 between any 
one mutant channel and the wild-type 
channel compared by Student’s t test). 
(E) Carbamazepine alters activation of 
the  Y1618K  plus  L1719E  double-mu-
tant channel. The activation curves of 
the mutant channel were done by the 
protocols  described  in  Materials  and 
methods. The lines are fits of the data from the same oocyte with a Boltzmann function with V1/2 values (in mV) of 26.9 and 16.8, 
and k values of 5.1 and 6.1 in the absence (black circles) and presence (white circles) of 300 µM carbamazepine. The averaged shift of 
the V1/2 of the activation curve by 300 µM carbamazepine is 7.2 ± 2.6 mV (n = 3). The inset contains representative currents elicited by a 
step depolarization to 20 mV from a holding potential of 120 mV. The dotted vertical line marks the time point when the peak mac-
roscopic current in control (black line) is reached. It is evident that 300 µM carbamazepine (red line) slows the macroscopic activation 
(rightward shifts the peak of macroscopic current) of the Y1618K plus L1719E mutant channel.  Yang et al. 109
of the channel pore traditionally linked by the selectiv-
ity filter, but also a more specific physical picture ac-
counting for the classical proposal of a “hydrophobic 
pathway” for local anesthetic binding to the Na
+ chan-
nel (Hille, 1977; see also Zhang et al., 2007). In this re-
gard,  it  is  notable  that  F1764  is  also  involved  in  the 
binding  site  of  batrachotoxin  (Linford  et  al.,  1998; 
Wang and Wang, 1999). Batrachotoxin is a lipid-soluble 
alkaloid neurotoxin and a specific Na
+ channel activa-
tor. The batrachotoxin binding site has been located   
in the domain “interface” chiefly involving D1S6 and 
D4S6 rather than in the main ion conduction pathway 
(Zamponi and French, 1994; Wang and Wang, 1999;   
De Leon and Ragsdale, 2003). With the idea of S6 re-
cess, batrachotoxin binding to F1764 thus may not block 
the channel pore (because it is in the S6 recess), but 
may  alter  ion  selectivity  (due  to  the  altered  W1716–
F1764 interaction; see Fig. 3). This is also reminiscent of 
the recent finding that charges at the position equiva-
lent to 1764 affect permeation in human cardiac Nav1.5 
(McNulty et al., 2007). The S6 recess also well explains 
the apparently perplexing finding that V1583C in skele-
tal Na
+ channels (equivalent to V1768 in Nav1.2 chan-
nels) could be modified by either internal or external 
MTESA,  and  that  the  modification  is  blocked  by  ba-
trachotoxin but not 20 mM of the internal pore-block-
ing  tetraethylammonium  (Vedantham  and  Cannon, 
2000). Together with the intriguing findings that I1760A 
but not I1760C makes the channel more sensitive to ex-
ternal  Cd
2+  block  (Wang  et  al.,  1998;  Sunami  et  al., 
2001), it seems plausible that the series of residues I1760-
F1764-V1768 may line a recess that is directly connected 
to the internal vestibule of the pore but are also inti-
mately associated with the external vestibule of the chan-
nel  pore.  Aromatic  side  chains  are  suggested  to  be 
critical for the proper folding and positioning of inte-
gral membrane proteins in the lipid bilayer because they 
are found enriched at the membrane–water interface 
and render the highest tendency to partition into the 
membrane–water interface (Wimley and White, 1996; 
Killian and von Heijne, 2000; Hessa et al., 2005). By the 
same token, W1716 and F1764 may build up and stabi-
lize a recess at an interface between the hydrophobic el-
ement, such as lipid bilayer and the hydrophilic path, 
that the permeating ions can actually travel through.
Membrane depolarization moves the S3-4 linker close  
to the pore loop in domain 4 to shape the anticonvulsant 
receptor in the external pore mouth
In  Fig.  5  we  show  that  a  point  mutation  Y1618K  in 
D4S3-4 linker makes the Na
+ channel inactivation ki-
netics evidently slowed by carbamazepine. This finding 
not only indicates that carbamazepine is turned into 
an ineffective pore blocker by the mutation, but also is 
very much reminiscent of the inactivation-deterring ef-
fect of external multivalent transitional pore-blocking 
in terms of the effect on carbamazepine binding affin-
ity, the non-additive feature of W1716 and F1764 muta-
tions suggests that the two residues do not independently 
contribute  to  the  drug  receptor.  Moreover,  the  esti-
mated interaction energy between W1716 and F1764 
falls into the range expected for two closely spaced in-
teracting aromatic side chains in a protein (Table I) 
(Serrano et al., 1991; Smith and Regan, 1995; Tatko and 
Waters, 2002; Hong et al., 2007). Second, F1764C re-
duces channel inactivation that is enhanced by W1716C 
and abolishes the accessibility of W1716C to the exter-
nal MTSET, MTSES, and Cd
2+. Third, the ion selectivity 
for Na
+ over K
+ of the W1716E mutant is abolished by 
introducing a countercharge at F1764 (i.e., F1764R). 
Fourth, double mutation of F1764R and G1715E (and 
also F1764R and L1719E) causes a large shift in the acti-
vation curve (but G1715E, L1719E, or F1764R single 
mutation does not have such an effect). These findings 
give rise to novel structural insight that the external 
pore-lining segment SS6 is located very close to the in-
ternal pore compartment of S6, enabling an alternative 
connection bypassing the selectivity filter between the 
external and internal compartments of the Na
+ channel 
pore.  This  alternative  connection  can  be  reasonably 
conceived because there must be a turn between the 
SS6 (the carboxyl end) of the pore loop and the S6 he-
lix (Fig. 11). In this regard, the S6 helix in the vicinity of 
F1764 may form a “recess” of the pore, so that the side 
chain at this F1764 position could present itself beside 
the SS6 pore loop to face the external part of the pore 
without trespassing the selectivity filter.
The “S6 recess” connects the internal and external 
vestibule of the channel pore: a revision of the pore 
configuration and the hydrophobic pathway of drug action
We have proposed that the external and internal parts 
of the pore might be connected by not only a narrow se-
lectivity filter in the pore, but also an interacting com-
mon “wall” between the “S6 recess” and the external 
pore mouth (Fig. 11). For the travelers bearing high 
charge  density  and  significant  inner  hydration  shell, 
such as metal ions, the only pathway through the pore is 
via the narrow selectivity filter that is equipped with 
coordinating  ligands  arranged  in  appropriate  spatial 
configuration to replace the water molecules in the hy-
dration shell. On the other hand, drug molecules that 
are uncharged or with lower charge density may inter-
act with the common wall between the external and in-
ternal parts of the pore, or even “sneak” across it. For 
instance, internal and external QX-314, a charged mol-
ecule with much lower charge density than inorganic 
ions, may both bind to the very “same” site in the pore, 
and then exit to the other side of the pore without trav-
eling through the selectivity filter. S6 recess thus would 
provide not only an innovative idea of the versatile de-
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interaction between the external S3-4 linker and the 
pore loop (e.g., via the double mutant of Y1618K plus 
L1719E) could alter the action of carbamazepine on 
gating kinetics while keeping the gating kinetics rela-
tively unchanged in the absence of the drug (Fig. 10, 
C–E). The effect of external Y1618K-L1719E interac-
tion thus is most likely ascribable to a truly local mech-
anism rather than an allosteric mechanism due to gating 
alteration.  Collectively,  the  anticonvulsant  receptor 
should be intimately related to the D4S3-4 linker and 
the  D4  pore  loop,  and  thus  it  directly  involves  the   
external region of the Na
+ channel pore. Consistently, 
site-3 neurotoxins were shown to bind to the D4S3-4 
linker  and  the  pore  loops  of  domains  1  and  4  to   
slow Na
+ channel inactivation (Tejedor and Catterall, 
1988; Thomsen and Catterall, 1989; Rogers et al., 1996; 
metal ions (Kuo et al., 2004) or -scorpion toxins (site-3 
neurotoxins; Tejedor and Catterall, 1988; Thomsen 
and  Catterall,  1989;  Rogers  et  al.,  1996;  Benzinger   
et al., 1998). In this regard, it is interesting to note that 
although carbamazepine, phenytoin, and lamotrigine 
bind to an external common anticonvulsant receptor 
with a structurally similar dephenyl motif (Kuo, 1998a; 
Kuo et al., 2000), they do have a very different inactiva-
tion-slowing effect in the Y1618K channel (Fig. 7 A). 
Moreover, many concomitant point mutations in the 
adjacent (but not more distant) areas in the D4S3-4 
linker and D4S4 abolish the inactivation-slowing effect 
of carbamazepine with Y1618K. The inactivation-deter-
ring effect is thus very likely ascribable to a delicate 
and local conformational change (rather than a long-
range allosteric interaction). In addition, the direct   
Figure 11.  A model illustrating the close proximity 
and interactions among the S3-4 linker (e.g., Y1618), 
the SS6 pore loop (e.g., W1716), and the internal 
pore-lining part of S6 (e.g., F1764) in domain 4 of 
the Na
+ channel, making a pivotal apparatus for ion 
permeation,  activation-inactivation  coupling,  and 
drug  binding.  (A)  The  transmembrane  segments 
S3–S6 in domain 4 of the channel are plotted as rect-
angular cylinders and viewed from the pore. W1716 
is adjacent to A1714 in sequence, and thus is most 
likely located externally to the selectivity filter in the 
SS6 pore loop. This position could reasonably inter-
act with F1764 of S6 if there is a turn at the junction 
of SS6 loop and S6 helix. As a result, the S6 helix in 
the vicinity of F1764 forms a “recess” of the pore. 
The aromatic residues Y1618, W1716, and F1764 are 
plotted as yellow dots. Membrane voltage changes 
move the S4 segment, and thus move the S3-4, S4-5, 
and S5-6 linkers to contribute to the essential volt-
age-dependent  physiological  and  pharmacological   
attributes of the channel. (B) An enlarged picture   
for the interacting aromatic residues in A. (C) A   
homology model for the S6 recess of domain 4   
in Nav1.2 based on the crystallized structure of the 
KcsA  K
+  channel  pore  (done  by  an  online  server 
provided  by  the  Swiss  Institute  of  Bioinformat-
ics:  http://swissmodel.expasy.org).  Because  of  the 
marked difference in the length of the pore loops 
between these two types of channels, the homology 
modeling is based on somewhat arbitrary sequence 
alignment of the key conservative residues of D4SS6 
and S6 (marked by green and orange rectangles, re-
spectively) in the Nav1.2 channel and a subunit in 
the KcsA channel, with a large portion of pore loop in Nav1.2 deleted (top panel; note the sequence numbering and the arrows indi-
cating W1716 and F1764). In the molecular model (bottom panel), the S5, S6, and S5-S6 linker of domain 4 are shown as space fills 
and colored gray, orange, and dark green, respectively. A1714 is in light green to mark the possible location of the selectivity filter. The 
aromatic side chains of W1716 in SS6 and F1764 in S6 are shown in yellow. A carbamazepine molecule could be well docked to a recep-
tor constituted by W1716 and F1764 in the recess region of this model with the Discovery Studio software (Accelyrs Inc.; not depicted). 
(D) The brown-colored areas illustrate the other part of the channel protein surrounding the aqueous pore region (light blue), which 
is made by the four SS5-SS6 loops from the four domains (illustrated as the four “walls” making the external part of the pore). W1716 
on the SS5-SS6 loop and F1764 on S6 (dotted helix; both residues depicted as yellow phenyl groups) of domain 4 interact to form a 
recess, which is more readily depicted with an angle of view roughly perpendicular to that in A and B. The anticonvulsant drug (shown 
as a pink diphenyl motif) presumably binds to its receptor located at the S6 recess with dipole-induced dipole interactions among the 
phenyl groups of the drug (pink), W1716 and F1764 (both in yellow; the boxed picture). A hydrophobic drug molecule of suitable 
conformation could even go through the S6 recess and thus traverse the pore without trespassing on the selectivity filter, embodying the 
long-proposed “hydrophobic” pathway of local anesthetic action on the Na
+ channel.  Yang et al. 111
indicates specific conformations (of the D4 external 
pore region) permissive for either channel activation or 
inactivation, or, very likely, permissive for the S4 move-
ment in one domain but not in the other. Channel acti-
vation  then  could  give  rise  to  specific  “intermediate” 
conformational changes in the D4 external pore region. 
These changes are deemed intermediate because they 
could not yet affect the occurrence of channel inactiva-
tion or the movement of D4S4. In summary, it seems 
plausible that the moving S4 upon membrane voltage 
changes has significant interactions with the pore do-
main on both ends. Those interactions on the intracel-
lular side may involve the S4-5 linker (e.g., McPhee et al., 
1998) to “pull” on the more carbonyl-end part of S6, 
where the activation/inactivation gates are presumably 
located. In contrast, the interactions on the extracellu-
lar side are most likely relayed from the voltage sensor to 
the external pore loop via the S3-4 linker, and are re-
sponsible for the stepwise conformational changes closely 
related to activation-inactivation coupling. The interac-
tions on the two ends may finally merge at or near the S6 
recess. The inner part of the external vestibule of the 
Na
+ channel pore may therefore not only have a critical 
function in ion permeation by constituting the selectiv-
ity filter of the channel, but also serve as a pivotal point 
transducing and coordinating the essential gating con-
formational changes. This could be the reason why this 
part of the Na
+ channel also makes an ideal receptor 
site for many important gating-modifying and/or pore-
blocking drugs and neurotoxins.
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